Integral Health Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Hold
15,000
0.71% 43
2026
Q1
$13.8M Sell
15,000
-5,000
-25% -$5.07M 0.66% 37
2025
Q4
$21.5M Hold
20,000
1.07% 30
2025
Q3
$15.3M Sell
20,000
-5,000
-20% -$3.72M 1.03% 29
2025
Q2
$19.5M Buy
+25,000
New +$19.4M 1.78% 16
2025
Q1
Sell
-38,000
Closed -$29.3M 98
2024
Q4
$29.3M Buy
38,000
+28,000
+280% +$23.2M 2.5% 9
2024
Q3
$8.86M Hold
10,000
1% 29
2024
Q2
$9.05M Sell
10,000
-2,000
-17% -$1.6M 0.86% 39
2024
Q1
$9.34M Sell
12,000
-16,000
-57% -$11.4M 0.87% 45
2023
Q4
$16.3M Buy
28,000
+3,000
+12% +$1.75M 2.22% 12
2023
Q3
$13.4M Sell
25,000
-5,000
-17% -$2.58M 1.86% 19
2023
Q2
$14.1M Buy
+30,000
New +$12.6M 1.74% 16
2022
Q4
Sell
-25,000
Closed -$8.08M 81
2022
Q3
$8.08M Sell
25,000
-48,059
-66% -$15.2M 1.57% 25
2022
Q2
$23.7M Buy
+73,059
New +$21.9M 4.87% 3
2021
Q1
Sell
-50,000
Closed -$8.44M 83
2020
Q4
$8.44M Buy
+50,000
New +$7.47M 2.51% 15
2020
Q3
Sell
-35,000
Closed -$5.75M 83
2020
Q2
$5.75M Buy
+35,000
New +$5.37M 1.72% 27
2020
Q1
Sell
-50,000
Closed -$6.57M 68
2019
Q4
$6.57M Buy
+50,000
New +$5.8M 2.56% 19

Other funds holding LLY

Integral Health Asset Management's LLY Position: Q2 2026 in Review

Integral Health Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 15,000 shares worth $18M. The position accounts for 0.71% of the portfolio, ranked #43.

Integral Health Asset Management first reported a position in LLY in Q4 2019 and has held it in 17 quarters since. The position peaked at $29.3M in Q4 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Integral Health Asset Management held 15,000 shares of Eli Lilly worth $18M as of Q2 2026.
  • Integral Health Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.71% of Integral Health Asset Management's portfolio in Q2 2026, its #43 holding.
  • Integral Health Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 17 quarters since.
  • Integral Health Asset Management's Eli Lilly position peaked at $29.3M in Q4 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.